导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.07% | 188/746 |
| 近一周 | -0.02% | 801/862 |
| 近一月 | -0.35% | 655/856 |
| 近一季 | 0.27% | 572/829 |
| 近半年 | 1.22% | 266/795 |
| 近一年 | 2.67% | 261/744 |
| 近两年 | 6.70% | 366/632 |
| 近三年 | 13.10% | 152/579 |
| 成立以来 | 37.51% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
0.62% 164/755 |
1.54% 133/838 |
0.43% 325/871 |
- - |
| 2024 | 2.60% 631/819 |
1.10% 1812/3226 |
0.98% 2261/3360 |
-1.31% 767/800 |
1.84% 436/819 |
| 2023 | 7.09% 62/3108 |
3.55% 28/2776 |
1.40% 605/2849 |
0.14% 2663/2940 |
1.85% 74/3108 |
| 2022 | 0.48% 2202/2727 |
-0.04% 1813/1949 |
2.03% 39/2522 |
-3.09% 2486/2598 |
1.67% 13/2732 |
| 2021 | 3.56% 1444/2409 |
-0.96% 1970/2068 |
1.06% 1044/2668 |
2.06% 196/2731 |
1.38% 458/2416 |
| 2020 | 2.15% 1296/2196 |
1.70% 1082/1576 |
0.09% 497/2274 |
-0.03% 1111/2475 |
0.39% 2168/2563 |
| 2019 | 4.88% 337/1720 |
1.24% 369/605 |
1.14% 69/637 |
1.31% 550/1762 |
1.10% 658/1956 |
| 2018 | 7.40% 262/1267 |
- - |
- - |
- - |
1.53% 370/593 |
| 2017 | 2.74% 181/1017 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8048 | 37.74% |
| 泰信现代服务业混合 | 2.0450 | 32.88% |
| 易方达标普生物科技人民币A | 1.7298 | 28.02% |
| 永赢高端装备智选混合发起A | 1.1625 | 27.65% |
| 永赢高端装备智选混合发起C | 1.1467 | 27.52% |
| 金信稳健策略混合A | 2.2741 | 23.08% |
| 金信精选成长混合A | 1.6584 | 22.49% |
| 金信精选成长混合C | 1.6361 | 22.31% |
| 东方人工智能主题混合C | 1.5534 | 22.12% |
| 金信行业优选混合发起式A | 2.7474 | 21.61% |
| 平安惠金定开债A VS. () |